Congenital Prothrombin Deficiency
- سال انتشار: 1397
- محل انتشار: مجله تحقیقات بیهوشی سلولی و مولکولی، دوره: 3، شماره: 4
- کد COI اختصاصی: JR_SBMU-3-4_002
- زبان مقاله: انگلیسی
- تعداد مشاهده: 442
نویسندگان
Department of laboratory sciences, School of Allied Medicine, Arak University of Medical Sciences, Arak, Iran
Department of Hematology and Blood transfusion, School of Allied Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Department of Hematology and Blood transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
Department of Hematology and Blood transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
Shariati hospital, Tehran University of Medical Sciences, Tehran, Iran
Department of Hematology and Blood transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
چکیده
Congenital prothrombin deficiency is an extremely rare hemorrhagic disorder with estimated prevalence of 1 per 2,000,000 in the general population. Since the disorder is an autosomal recessive disorder, the disorder is more frequent in areas with high rate of consanguinity. Clinical manifestations of the disorder are highly variable ranging from mild bleeding episodes to severe life-threatening hemorrhages. The disorder can be diagnosed based on routine and specific tests. Deficiency in concentration of specific factor II (FII) is available, but patients can receive fresh frozen plasma (FFP) and prothrombin complex concentrate (PCC). Traditionally patients with prothrombin deficiency receive on-demand therapy, but secondary prophylaxis can be used for those patients with high risk of severe life-threatening bleeding. With timely diagnosis and appropriate management of disorder quality of life in these patients can significantly improve.کلیدواژه ها
Prothrombin deficiency, Clinical manifestations, Diagnosis, Treatmentمقالات مرتبط جدید
- Phenolic fraction concentrates supplementation ameliorates learning and memory impairments in chronically stressed streptozotocin-diabetic rats by reducing brain tumor necrosis factor-α
- Chemical composition of Prangos ferulacea (L.) Lindl., and Prangos uloptera DC. essential oils and their antifungal activities
- Effect of ethyl acetate fraction of Costus afer on glycaemic control and essential haematological and biochemical indices of streptozotocin-induced diabetic rats
- Insulin supplemented with phenolic fraction concentrates displays anxiolytic and antidepressant-like properties with reductions of oxidative brain damage in chronically stressed diabetic rats
- Evaluation of erythrocyte viability, antioxidant capacity and antiplasmodial activity induced by alkaloid extract of Phyllanthus amarus
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.